The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1.

PubWeight™: 2.79‹?› | Rank: Top 1%

🔗 View Article (PMID 11237825)

Published in J Infect Dis on February 28, 2001

Authors

C C Wang1, R S McClelland, M Reilly, J Overbaugh, S R Emery, K Mandaliya, B Chohan, J Ndinya-Achola, J Bwayo, J K Kreiss

Author Affiliations

1: Departments of Medicine and Epidemiology, Division of Infectious Diseases, University of Washington, Seattle, WA 98104-2499, USA. chiaw@u.washington.edu

Articles citing this

Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med (2011) 5.21

Deep sequencing of the vaginal microbiota of women with HIV. PLoS One (2010) 2.59

Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis (2009) 2.30

The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women. Sex Transm Infect (2011) 2.19

Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? AIDS (2010) 2.17

Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med (2012) 2.06

Candida infections of the genitourinary tract. Clin Microbiol Rev (2010) 1.90

Validation of performance of the gen-probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples. J Clin Microbiol (2002) 1.82

Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples. J Clin Microbiol (2006) 1.67

Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol (2006) 1.55

Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microbiol Rev (2009) 1.46

Trichomoniasis and other sexually transmitted infections: results from the 2001-2004 National Health and Nutrition Examination Surveys. Sex Transm Dis (2009) 1.45

Targeting Trojan Horse leukocytes for HIV prevention. AIDS (2010) 1.40

Use of the Roche LightCycler instrument in a real-time PCR for Trichomonas vaginalis in urine samples from females and males. J Clin Microbiol (2003) 1.39

Trichomoniasis and HIV interactions: a review. Sex Transm Infect (2013) 1.36

Interactions of HIV, other sexually transmitted diseases, and genital tract inflammation facilitating local pathogen transmission and acquisition. Am J Reprod Immunol (2011) 1.32

Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota. AIDS Res Hum Retroviruses (2010) 1.26

Genital tract leukocytes and shedding of genital HIV type 1 RNA. Clin Infect Dis (2008) 1.25

Prevalence of sexually transmitted infections among pregnant women with known HIV status in northern Tanzania. Reprod Health (2009) 1.25

Antiretroviral therapy as HIV prevention: status and prospects. Am J Public Health (2010) 1.25

Trichomonas vaginalis genital infections: progress and challenges. Clin Infect Dis (2011) 1.22

Trichomonas vaginalis infection in women who submit self-obtained vaginal samples after internet recruitment. Sex Transm Dis (2011) 1.21

Correlates of HIV-1 genital shedding in Tanzanian women. PLoS One (2011) 1.19

The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment. Sex Transm Dis (2005) 1.17

Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care. Sex Transm Dis (2012) 1.10

A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr (2010) 1.07

Sexually transmitted infections among HIV-1-discordant couples. PLoS One (2009) 1.06

On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections. Expert Rev Anti Infect Ther (2013) 1.06

Non-sexual transmission of Trichomonas vaginalis in adolescent girls attending school in Ndola, Zambia. PLoS One (2011) 1.06

The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract. Curr HIV Res (2012) 1.05

Stepwise diagnosis of Trichomonas vaginalis infection in adolescent women. J Clin Microbiol (2008) 1.05

Trichomonas vaginalis infection: can we afford to do nothing? J Infect Dis (2008) 1.03

A Trich-y question: should Trichomonas vaginalis infection be reportable? Sex Transm Dis (2013) 1.02

Neglected parasitic infections in the United States: trichomoniasis. Am J Trop Med Hyg (2014) 1.02

Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters. AIDS Res Hum Retroviruses (2013) 1.02

Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women. Sex Transm Dis (2010) 1.00

Comparison of latex agglutination, wet preparation, and culture for the detection of Trichomonas vaginalis. Sex Transm Infect (2004) 0.97

Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. BMC Infect Dis (2015) 0.96

Positive association between HIV RNA and IL-6 in the genital tract of Rwandan women. AIDS Res Hum Retroviruses (2008) 0.94

Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women. Sex Transm Dis (2011) 0.94

Effect of treatment of asymptomatic bacterial vaginosis on HIV-1 shedding in the genital tract among women on antiretroviral therapy: a pilot study. Clin Infect Dis (2009) 0.92

A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women. Sex Transm Dis (2013) 0.90

The role of co-infections in mother-to-child transmission of HIV. Curr HIV Res (2013) 0.90

Characteristics and quantities of HIV host cells in human genital tract secretions. J Infect Dis (2014) 0.89

Effect of trichomoniasis therapy on genital HIV viral burden among African women. Sex Transm Dis (2012) 0.89

Mycoplasma genitalium infection among HIV-positive women: prevalence, risk factors and association with vaginal shedding. Int J STD AIDS (2011) 0.86

Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents. J Reprod Immunol (2012) 0.85

Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence. Sex Transm Dis (2013) 0.85

The Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the Literature. J Sex Transm Dis (2013) 0.83

Epidemiology and treatment of trichomoniasis. Curr Infect Dis Rep (2015) 0.82

Genetic diversity of Trichomonas vaginalis reinfection in HIV-positive women. Sex Transm Infect (2013) 0.79

Short-term effect of zidovudine on plasma and genital human immunodeficiency virus type 1 and viral turnover in these compartments. J Virol (2003) 0.79

A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy. BMC Infect Dis (2011) 0.79

Ginger (Zingiber officinale) induces apoptosis in Trichomonas vaginalis in vitro. Int J Reprod Biomed (Yazd) (2016) 0.78

Clinical parameters essential to methodology and interpretation of mucosal responses. Am J Reprod Immunol (2011) 0.78

Expanding sexually transmitted infection screening among women and men engaging in transactional sex: the feasibility of field-based self-collection. Int J STD AIDS (2013) 0.77

Can one size fit all? Approach to bacterial vaginosis in sub-Saharan Africa. Ann Clin Microbiol Antimicrob (2016) 0.77

Oral HHV-8 replication among women in Mombasa, Kenya. J Med Virol (2014) 0.77

Trichomoniasis: What's New? Curr Infect Dis Rep (2003) 0.76

Lower Genital Tract Infections in HIV-Infected Women: Can We Afford to Miss? J Obstet Gynaecol India (2014) 0.76

Viral sequence analysis of HIV-positive women and their infected children: insight on the timing of infection and on the transmission network. AIDS Res Hum Retroviruses (2014) 0.75

Strategies for Prevention and Treatment of Trichomonas vaginalis Infections. Clin Microbiol Rev (2017) 0.75

Use of Sno Strip filter-paper wicks for collection of genital-tract samples allows reproducible determination of human immunodeficiency virus type 1 (HIV-1) RNA viral load with a commercial HIV-1 viral load assay. J Clin Microbiol (2006) 0.75

Vaginal HIV-1 shedding among HIV-1 infected women in the current era of combined antiretroviral therapy: A cross sectional study. Virulence (2016) 0.75

Rapid Antigen Testing for Trichomoniasis in an Emergency Department. Pediatrics (2016) 0.75

Genotyping, Drug Susceptibility and Prevalence Survey of Trichomonas vaginalis among Women Attending Gynecology Clinics in Hamadan, Western Iran, in 2014-2015. Iran J Parasitol (2017) 0.75

Molecular characterization of double-stranded RNA virus in Trichomonas vaginalis Egyptian isolates and its association with pathogenicity. Parasitol Res (2016) 0.75

Barriers to HIV remission research in low- and middle-income countries. J Int AIDS Soc (2017) 0.75

Articles by these authors

Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA (2000) 10.40

The origin of mutants. Nature (1988) 8.92

Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis (1991) 7.05

Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA (1992) 6.99

Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis (1999) 6.85

Effect of circumcision on incidence of human immunodeficiency virus type 1 and other sexually transmitted diseases: a prospective cohort study of trucking company employees in Kenya. J Infect Dis (1999) 5.86

Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: A randomized clinical trial. JAMA (2001) 5.77

The right not to know HIV-test results. Lancet (1995) 5.16

Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial. Lancet (2001) 5.10

Gender differences in HIV-1 diversity at time of infection. Nat Med (2000) 4.69

AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa. N Engl J Med (1986) 4.68

Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol (1997) 4.19

Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol (1999) 3.88

Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol (2000) 3.83

Sigmoid Myotomy [Abridged]. Proc R Soc Med (1964) 3.60

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest (1998) 3.53

Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology (2005) 3.44

Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat Med (1999) 3.11

Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis (2000) 3.02

Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J Virol (1995) 2.98

Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis (1998) 2.96

Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol (1999) 2.90

Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J Virol (1997) 2.88

Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet (1997) 2.88

Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet (1996) 2.76

Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet (2000) 2.74

Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol (1988) 2.62

Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis (1998) 2.61

Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA (1993) 2.41

Partner notification by HIV-1 seropositive pregnant women: association with infant feeding decisions. AIDS (2001) 2.30

Estimation of genetic and environmental factors for binary traits using family data. Stat Med (2004) 2.22

Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J Virol (1998) 2.21

The importance of core groups in the epidemiology and control of HIV-1 infection. AIDS (1991) 2.21

Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates. Virology (1995) 2.08

Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis (1997) 2.02

Human immunodeficiency virus infection in long-distance truck drivers in east Africa. Arch Intern Med (1994) 2.01

Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition. J Virol (1998) 1.98

Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol (2001) 1.95

Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests. J Clin Microbiol (2000) 1.95

Mother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study. J Infect Dis (1994) 1.94

The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. J Infect Dis (1996) 1.88

Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS (2001) 1.88

Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion. J Infect Dis (1995) 1.86

Heterosexual transmission of HIV. AIDS (1987) 1.84

Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J Virol (1991) 1.83

The use of postoperative suction drainage in total knee arthroplasty. Clin Orthop Relat Res (1986) 1.83

Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Evidence for heterosexual transmission. Ann Intern Med (1985) 1.82

Lymphocyte subsets in human immunodeficiency virus type 1-infected and uninfected children in Nairobi. Pediatr Infect Dis J (2001) 1.81

Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis (1999) 1.80

Distinct but related human immunodeficiency virus type 1 variant populations in genital secretions and blood. AIDS Res Hum Retroviruses (1996) 1.76

Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis (1998) 1.74

Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis (1994) 1.70

Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia. Blood (2000) 1.64

Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Côte d'Ivoire. AIDS (1997) 1.63

Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: results of a study of couples in Nairobi, Kenya. J Infect Dis (1991) 1.62

Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis (1995) 1.62

HIV infection among lower socioeconomic strata prostitutes in Nairobi. AIDS (1990) 1.62